A centralized Pharmacy Unit for cytotoxic drugs in accordance with Italian legislation

Journal of Evaluation in Clinical Practice

Volumn 13, Issue 2, 2007, Pages 265-271

  Baldo, Paolo ^a   Bertola, Antonella ^a   Basaglia, Giancarlo ^a   Moneghini, Mariarosa ^b   Sorio, Roberto ^a   Zibardi, Enrico ^c   Lazzarini, Renzo ^a   De Paoli, Paolo ^a  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^b UNIVERSITY OF TRIESTE   (Italy)

^c Italian Society of Hospital Pharmacists   (Italy)

Author keywords

Antineoplastic drug; Cytotoxic drug; Legislation; Pharmacy service

Indexed keywords

ANTINEOPLASTIC AGENT; AZACITIDINE; AZATHIOPRINE; BLEOMYCIN; CHLORAMBUCIL; CISPLATIN; CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT; DACARBAZINE; DAUNORUBICIN; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; MELPHALAN; METHOTREXATE; VINBLASTINE; VINCRISTINE;

ARTICLE; CARCINOGENICITY; DRUG FORMULATION; DRUG INDUSTRY; DRUG MARKETING; DRUG QUALITY; DRUG STABILITY; DRUG STERILITY; DRUG SURVEILLANCE PROGRAM; HEALTH CARE PERSONNEL; HUMAN; ITALY; LAW; MEDICAL SOCIETY; OCCUPATIONAL EXPOSURE; PHARMACY; PRIORITY JOURNAL; RISK ASSESSMENT;

CYTOTOXINS; DRUG COMPOUNDING; GUIDELINE ADHERENCE; HUMANS; ITALY; PHARMACY SERVICE, HOSPITAL;

EID: 33947371659     PISSN: 13561294     EISSN: 13652753     Source Type: Journal    
DOI: 10.1111/j.1365-2753.2006.00693.x     Document Type: Article

References (31)

1. Reich, S. D. (1981) Pharmaceutics: antineoplastic agents as potential carcinogens: are nurses and pharmacists at risk? Cancer Nursing, 4 (6), 500-502.
2. IARC. (1987-2005) Monographs on the Evaluation of Carcinogenic Risks to Humans and Their Supplements: A Complete List. Available through website: http://www-cie.iarc.fr/monoeval/allmonos.html (last accessed 30 July 2005).
3. Valanis, B. & Vollmer, W., Labuln, K. & Glass, A. (1997) Occupational exposure to antineoplastic agents and self-reported infertility among nurses and pharmacists. Journal of Occupational and Environmental Medicine, 39, 574-580.
4. Selevan, S. G., Lindbohm, M. L., Hornung, R. W. & Hemminki, K. (1985) A study of occupational exposure to antineoplastic drugs and fetal loss in nurses. New England Journal of Medicine, 313 (19), 1173-1178. Available at: http://content.njem.org/cgi/search (last accessed 28 July 2005).
5. Anderson, R. W., Puckett, W. H. Jr, Dana, W. J., Nguyen, T. V., Theiss, J. C. & Matney, T. S. (1982) Risk of handling antineoplastic agents. American Journal of Hospital Pharmacy, 39, 1881-1887. Available at: http://www.ajhp.org/ (last accessed 30 July 2005).
6. American Society of Hospital Pharmacists. (1990) ASHP Technical assistance bulletin on handling cytotoxic and hazardous drugs. American Journal of Hospital Pharmacy, 47, 1033-1049. Available at: http://www.ajhp.org/ (last accessed 28 July 2005).
7. Alwood, M., Stanley, A. & Wright, P. (2002) The Cytotoxics Handbook, 4th edn. Abingdon, UK: Radcliffe Medical Press. Contact at website: http://www.radcliffe-oxford.com
8. Gruppo di Lavoro in Oncologia S.I.F.O. Lombardia; Società Italiana di Farmacia Ospedaliera (S.I.F.O.). (2003) Compendio Farmacologico e Tecnico-Farmaceutico alle Linee-Guida S.I.F.O. in Oncologia. Milano: Edizioni MDM Medical Media, Available at: http://www.cesimultimedia.it/cmp02/ (last accessed 29 July 2005).
9. Chrystal, C. (1997) Administering continuous vesicant chemotherapy in the ambulatory setting. Journal of Intravenous Nursing, 20 (2), 78-88.
10. Ener, R. A., Meglathery, S. B. & Styler, M. (2004) Extravasation of systemic hemato-oncological therapies. Annals of Oncology, 15 (6), 858-862.
11. Minoia, C., Turci, R., Bartolucci, G. B., Signorini, S. & Apostoli, P. (2000) Progressi nella valutazione del rischio espositivo da chemioterapici antiblastici. Convegno Nazionale. Pavia: Maugeri Foundation Books - I Libri della Fondazione Maugeri PI-ME Press. Available at: http://www.fsm.it/libri/ (last accessed 30 July 2005).
12. Italian Official Gazette n. 242 (1996), n. 47, 191 and 236 (1999), n. 70 (2000), n. 57 and 115 (2002) Roma: Istituto Poligrafico e Zecca dello Stato.
13. Italian Official Gazette (ordinary supplements) n. 265 (1994), n. 7 (1993), n. 104 (1996) Roma: Istituto Poligrafico e Zecca dello Stato.
14. Ministero Della Salute & Istituto Superiore di Sanità, Commissione Permanente per la Revisione e la Pubblicazione della Farmacopea Ufficiale. (2002) Farmacopea Ufficiale della Repubblica Italiana XI Edizione. Roma: Istituto Poligrafico e Zecca dello Stato.
15. Trissel, L. A. (2002) Handbook on Injectable Drugs, 12th edn (1522 pages). Bethesda, Maryland: American Society of Health-System Pharmacists. ISBN: 1585280410. Available at website: http://shop.ashp.org/timssnet/common/ tnt_frontpage.cfm (accessed 31 July 2005) or at http://www.ashp.org/index.cfm (accessed 31 July 2005).
16. Deffenbaugh, J. H. (2000) Risks of using technicians and not pharmacists to handle antineoplastic drugs. American Journal of Health-System Pharmacy, 57, 1750-1753.
17. Henn-Menetre, S., Noirez, V., Husson, J., Vallance, C., Lestreit, J. M., Llorens, A. M., May, I., Grandhaye, J. P. & Bey, P. (2003) Training of pharmacy personnel in the management of a centralized unit: the Oncolor network experience. Bulletin of the Cancer, 90 (10), 910-916.
18. Lifshin, L. & Nimmo, C. (2001) Developing and maintaining up-to-date training for pharmacy technicians. American Journal of Health System Pharmacy, 58 (11), 968-70. Available at: http://www.ajhp.org/ (last accessed 29 July 2005).
19. Sessink, P. J. & Bos, R. P. (1999) Drugs hazardous to healthcare - occupational exposure to cytostatic drugs. Drug Safety, 20 (4), 347-359.
20. Colombo, P., Gunnarsson, K., Iatropoulos, M. & Brugnera, M. (2001) Toxicological testing of cytotoxic drugs (Rview). International Journal of Oncology, 19, 1021-1028.
21. Connor, T. H., Anderson, R. W., Sessink, P. J. & Spivey, S. M. (2002) Effectiveness of a closed-system device in containing surface contamination with cyclophosphamide and ifosfamide in an i.v. admixture area. American Journal of Health-System Pharmacy, 59, 68-72. Available at: http://www.ajhp.org/ (last accessed 29 July 2005).
22. Koppel, R., Metlay, J. P., Cohen, A., Abaluck, B., Russell Localio, A., Kimmel, S. E. & Strom, B. L. (2005) Role of computerized physician order entry systems in facilitating medication errors. Journal of the American Medical Association, 293, 1197-1203. Available at: http://Jama.ama-assn.org/ (last accessed 2005, July 29).
23. American Society of Health-System Pharmacists. (2002) ASHP guidelines on preventing medication errors with antineoplastic agents. American Journal of Hospital Pharmacy, 59, 1649-1669. Available at: http://www.ajhp.org/ (last accessed 28 July 2005).
24. Favier, B., Gilles, L., Desage, M. & Latour, J. F. (2003) Analysis of cyclophosphamide in the urine of antineoplastic drugs handlers. Bulletin of the Cancer, 90 (10), 905-909 (French).
25. Sottani, C., Tranfo, G., Faranda, P. & Minoia, C. (2005) Highly Highly sensitive high-performance liquid chromatography/selective reaction monitoring mass spectrometry method for the determination of cyclophosphamide and ifosfamide in urine of health care workers exposed to antineoplastic agents. Rapid Communications in Mass Spectrometry, 19 (19), 2794-2800.
26. NIH - Public Health Service. National Institutes of Health. (1992) Recommendations for the Safe Handling of Parenteral Antineoplastic Drugs. Washington, DC: US Department of Health and Human Services. (NIH publication 83-2621, updated in, by NIH publication 92-2621). Available at: http://www.nih.gov/od/ors/ds/pubs/cyto/index.htm (last accessed 28 July 2005).
27. AMA Council of Scientific Affairs. (1985) Guidelines for handling parenteral antineoplastics. Journal of the American Medical Association, 253, 590-592. Available at: http://Jama.ama-assn.org/ (accessed 29 July 2005).
28. Office of Occupational Medicine, Occupational Safety and Health Administration (OSHA) (1986) OSHA work-practice guidelines for personnel dealing with cytotoxic (antineoplastic) drugs. American Journal of Hospital Pharmacy, 43, 1193-1204. Available at: http://www.ajhp.org/ (accessed 28 July 2005).
29. Office of Occupational Medicine, Occupational Safety and Health Administration (OSHA) (1996) Controlling occupational exposure to hazardous drugs. American Journal of Health-System Pharmacy, 53, 669-85. Available at: http://www.osha.gov (last accessed March 2005).
30. Health and Safety Executive (HSE) (2003) Information Sheet MISC 615: Safe Handling of Cytotoxic Drugs, UK. Available at: http://www.hse.gov.uk/ pubns/misc615.pdf (last accessed 29 July 2005).
31. NIOSH Publication No 2004-165 (2004) Alert on Preventing Occupational Exposure to Antineoplastic and Other Hazardous Drugs in Health Care Settings. Available at: http://www.cdc.gov/niosh/docs/2004-165 (last accessed April 2005).